Polo-like kinase 3 is required for entry into S phase

被引:81
|
作者
Zimmerman, Wendy C. [1 ]
Erikson, Raymond L. [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
关键词
Cdc25A; cyclin E; nucleolus;
D O I
10.1073/pnas.0610856104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The polo-like kinase, Plk1, which is expressed and active in mitosis, is involved in regulation of mitotic entry, spindle pole assembly, mitotic exit, and cytokinesis [Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM (2001) J Cell Sci 114:2357-2358]. In mammals, there are two other members of the polo-like kinase family that are less well understood, Plk2 and Plk3. Plk3 first was identif ied and cloned as an immediate early gene. Here, we report Plk3 localizes to the nucleolus and is involved in regulation of the G(1)/S phase transition. We demonstrate that the level of Plk3 protein is cell cycle regulated, peaking in G(1). We have delivered Plk3interfering RNA with lentivirus to serum-starved cells and found that, upon serum stimulation, Plk3 is required for cyclin E expression and entry into S phase. Plk3-interfering RNA-induced Plk3 depletion resulted in a large fraction of asynchronously proliferating cells to become quiescent. We propose the Plk3 requirement in the cell cycle is fulfilled in G1, and that once cells pass this point, they are able to complete cell division, whereas in the absence of Plk3, they fail to reenter the cell cycle. Additional data suggest that Plk3 may regulate entry into S phase in part through interaction with the phosphatase Cdc25A, because its depletion also resulted in attenuation of cyclin E expression.
引用
收藏
页码:1847 / 1852
页数:6
相关论文
共 50 条
  • [21] The polo-like kinase Plk2 is required for centrosome duplication in mammalian cells
    Warnke, S
    Hames, R
    Kemmler, S
    Hoffmann-Rohrer, UW
    Fry, A
    Hoffmann, I
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2004, 83 : 79 - 79
  • [22] The CINs of Polo-Like Kinase 1 in Cancer
    Cunningham, Chelsea E.
    MacAuley, Mackenzie J.
    Vizeacoumar, Frederick S.
    Abuhussein, Omar
    Freywald, Andrew
    Vizeacoumar, Franco J.
    CANCERS, 2020, 12 (10) : 1 - 26
  • [23] The balance of Polo-like kinase 1 in tumorigenesis
    Lu, Lin-Yu
    Yu, Xiaochun
    CELL DIVISION, 2009, 4
  • [24] Polo-like Kinase1 Is Required for Recruitment of Dynein to Kinetochores during Mitosis
    Bader, Jason R.
    Kasuboski, James M.
    Winding, Michael
    Vaughan, Patricia S.
    Hinchcliffe, Edward H.
    Vaughan, Kevin T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (23) : 20769 - 20777
  • [25] Developing polo-like kinase 1 inhibitors
    Huang, Xufeng
    Xie, Zhouling
    Liao, Chenzhong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 869 - 871
  • [26] Human Polo-like Kinase Inhibitors as Antiplasmodials
    Bohmer, Monica J.
    Wang, Jinhua
    Istvan, Eva S.
    Luth, Madeline R.
    Collins, Jennifer E.
    Huttlin, Edward L.
    Wang, Lushun
    Mittal, Nimisha
    Hao, Mingfeng
    Kwiatkowski, Nicholas P.
    Gygi, Steven P.
    Chakrabarti, Ratna
    Deng, Xianming
    Goldberg, Daniel E.
    Winzeler, Elizabeth A.
    Gray, Nathanael S.
    Chakrabarti, Debopam
    ACS INFECTIOUS DISEASES, 2023, 9 (04): : 1004 - 1021
  • [27] Polo-like Kinase 4 Shapes Up
    Levine, Michelle S.
    Holland, Andrew J.
    STRUCTURE, 2014, 22 (08) : 1071 - 1073
  • [28] Polo-like kinase inhibitors in hematologic malignancies
    Talati, Chetasi
    Griffiths, Elizabeth A.
    Wetzler, Meir
    Wang, Eunice S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 200 - 210
  • [29] Regulation of cytokinesis by polo-like kinase 4
    Press, Michael F.
    Xie, Bin
    Davenport, Simon
    Zhou, Yu
    O'Brien, Neil
    Palazzolo, Michael
    Mak, Tak
    Brugge, Joan
    Slamon, Dennis J.
    CANCER RESEARCH, 2016, 76
  • [30] Progress in the discovery of polo-like kinase inhibitors
    McInnes, C
    Mezna, M
    Fischer, PM
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 181 - 197